NBS-nytt
25.11.2019
Prostate cancer is the most common cancer and the second most deadly male cancer in Norway with about 5,000 new cases diagnosed and approximately 1,000 deaths every year. Research challenges involving prostate cancer include improved methods for early detection as well as the development of new treatments and prognostic markers.
... Recent results that are recognized in the national and international press (1) and published in Nature Communications (2) by a research team at UiO headed by Professor Fahri Saatcioglu plus national and international partners focus on endoplasmic reticulum (ER) stress and the Unfolded Protein Response (UPR) as targets for treating prostate cancer. TostrhiimegiuUnlPaatRtiendigs gawesniiteghneaExlRptrresastnrsseiodsnsu,ctttoihoeanxt ppiaanntvhdowlvtaheyes, EcseaRcnrtwelythoeirnnycprcereoalltsseeidsnu, csfhyonratshexetashmies pplolaean,dcirnies anssoi.grnmRifeai--l cghereoniguthpwt,eohnraeksd, ispnhrcoolwulidfneinrtaghtiafotrnocmahnitcjhaeecrkSc' aetalhltseciwoUgPitlRuh tpmoaotsshutwpapeyovsrotlhugatrviooenwabtrheiel. yn-TciohdnreesneetrivdfieiefddferwpenaittthhUwtPhaRye iicngonvvoaetlrveeiddnga(s3aI)nRtEhE1aRti-nmhayesemabsbotrtawhnh
Gå til mediet
